Suppr超能文献

中国城市老年人群中与肺炎球菌疫苗接种相关的因素。

Factors associated with pneumococcal vaccination among an urban elderly population in China.

作者信息

Liu Shijun, Xu Erping, Liu Yan, Xu Yuyang, Wang Jun, Du Jian, Zhang Xiaoping, Che Xinren, Gu Wenwen

机构信息

a Hangzhou Center for Disease Control and Prevention ; Hangzhou , China.

出版信息

Hum Vaccin Immunother. 2014;10(10):2994-9. doi: 10.4161/21645515.2014.972155.

Abstract

OBJECTIVES

To investigate the coverage of the 23-valent pneumococcal polysaccharide vaccine (23-PPV) in the Chinese urban elderly population and to understand the attitudes, knowledge and beliefs of this population toward the 23-PPV vaccination.

METHODS

A cross-sectional approach was employed to survey the willingness of this population to receive the 23-PPV vaccination. Two thousand 9 hundred 2 six subjects over the age of 60 y were enrolled via a multi-stage random sampling method from the urban community population in Hangzhou, China. The relationships between the variables and the willingness to receive the 23-PPV vaccination were computed as odds ratios (ORs) by multivariate analysis.

RESULTS

Of the participants, 21.77% were willing to undergo 23-PPV vaccination, and 61.65% of the subjects agreed that pneumonia is a serious disease among elderly people. The rate of reasonable perceptions about vaccination, including the perception about vaccine efficacy and safety, among the subjects was below 50%. Only 1.23% of subjects had been vaccinated with 23-PPV, and a similarly low rate was observed for the seasonal influenza vaccine (4.17%). The factors that were independently related to the willingness to receive the 23-PPV vaccine included consensus with the hazards of pneumonia (OR = 1.67, 95% CI: 1.28 - 2.17), the safety of vaccination (OR = 2.00, 95% CI: 1.54 - 2.59), advice about the 23-PPV vaccination from family members (OR = 2.37, 95% CI: 1.39 - 4.40), influenza vaccination history (OR = 2.57, 95% CI: 1.66 - 3.98) and pneumococcal vaccination history (OR = 7.48, 95% CI: 2.4-22.92).

CONCLUSION

The administration of the 23-PPV vaccine among the urban elderly population is not optimistic in China. Emphasis on persuasion from families and the improvement of knowledge about vaccination might encourage elderly people to get the 23-PPV vaccination. Suggestions from physicians did not affect the participants' willingness to get the 23-PPV vaccination in multivariate analysis, but elderly people typically visited the Community Health Center (CHC) in their residential districts, and thus, systematic encouragement from healthcare physicians might be the key to increasing 23-PPV vaccination.

摘要

目的

调查23价肺炎球菌多糖疫苗(23-PPV)在中国城市老年人群中的覆盖情况,并了解该人群对23-PPV疫苗接种的态度、知识和观念。

方法

采用横断面研究方法调查该人群接种23-PPV疫苗的意愿。通过多阶段随机抽样方法,从中国杭州城市社区人群中纳入2926名60岁以上的受试者。通过多变量分析计算变量与接种23-PPV疫苗意愿之间的关系,以比值比(OR)表示。

结果

在参与者中,21.77%愿意接种23-PPV疫苗,61.65%的受试者认同肺炎在老年人中是一种严重疾病。受试者对疫苗接种的合理认知率,包括对疫苗有效性和安全性的认知,低于50%。仅1.23%的受试者接种过23-PPV疫苗,季节性流感疫苗的接种率同样较低(4.17%)。与接种23-PPV疫苗意愿独立相关的因素包括认同肺炎的危害性(OR = 1.67,95%CI:1.28 - 2.17)、疫苗接种安全性(OR = 2.00,95%CI:1.54 - 2.59)、家庭成员对23-PPV疫苗接种的建议(OR = 2.37,95%CI:1.39 - 4.40)、流感疫苗接种史(OR = 2.57,95%CI:1.66 - 3.98)和肺炎球菌疫苗接种史(OR = 7.48,95%CI:2.4 - 22.92)。

结论

中国城市老年人群中23-PPV疫苗的接种情况不容乐观。强调家庭劝说以及提高疫苗接种知识水平可能会促使老年人接种23-PPV疫苗。在多变量分析中,医生的建议并未影响参与者接种23-PPV疫苗的意愿,但老年人通常会前往其居住小区的社区卫生服务中心(CHC),因此,医护人员的系统性鼓励可能是提高23-PPV疫苗接种率的关键。

相似文献

1
Factors associated with pneumococcal vaccination among an urban elderly population in China.
Hum Vaccin Immunother. 2014;10(10):2994-9. doi: 10.4161/21645515.2014.972155.
2
The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Vaccine. 2015 Jun 9;33(25):2897-902. doi: 10.1016/j.vaccine.2015.04.068. Epub 2015 Apr 30.
3
Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
Clin Infect Dis. 2006 Oct 1;43(7):860-8. doi: 10.1086/507340. Epub 2006 Aug 21.
4
Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Vaccine. 2008 Oct 16;26(44):5633-40. doi: 10.1016/j.vaccine.2008.07.070. Epub 2008 Aug 14.
5
Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines.
Hum Vaccin Immunother. 2018 Jan 2;14(1):111-117. doi: 10.1080/21645515.2017.1387703. Epub 2017 Nov 29.
6
Predictors of pneumococcal polysaccharide vaccination among patients at three inner-city neighborhood health centers.
Am J Geriatr Pharmacother. 2005 Sep;3(3):149-59. doi: 10.1016/s1543-5946(05)80021-2.
9
Pneumococcal vaccination in the emergency department: an assessment of need.
Ann Emerg Med. 2004 Oct;44(4):386-92. doi: 10.1016/j.annemergmed.2004.05.007.

引用本文的文献

2
Determinants of pneumococcal vaccination behavior among elderly people aged ≥60 years in Jiangxi, China.
Medicine (Baltimore). 2025 May 30;104(22):e42597. doi: 10.1097/MD.0000000000042597.
5
Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific: Insights from the COVID-19 Pandemic.
Clin Interv Aging. 2023 May 31;18:869-880. doi: 10.2147/CIA.S406601. eCollection 2023.
6
A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2139123. doi: 10.1080/21645515.2022.2139123. Epub 2022 Nov 15.
7
Promote COVID-19 Vaccination for Older Adults in China.
China CDC Wkly. 2022 Sep 16;4(37):832-834. doi: 10.46234/ccdcw2022.173.
8
The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing.
Int J Chron Obstruct Pulmon Dis. 2021 Dec 8;16:3337-3346. doi: 10.2147/COPD.S340730. eCollection 2021.

本文引用的文献

5
Vaccines for preventing pneumococcal infection in adults.
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD000422. doi: 10.1002/14651858.CD000422.pub3.
7
[Technical guideline on application of pneumococcal vaccine in China (2012)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Nov;33(11):1101-10.
10
Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
Expert Rev Vaccines. 2011 Aug;10(8):1143-67. doi: 10.1586/erv.11.99. Epub 2011 Aug 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验